Presently recommended biomarkers for lung cancer include carcinoembryonic antigen (CEA), progastrin‐releasing peptide (ProGRP), cytokeratin 19 fragment (Cyfra21‐1), neuron‐specific enolase (NSE), and squamous cell carcinoma antigen (SCC). This evidence concerns the gene CEACAM5 and lung carcinoma.